Frontiers of Science Awardを受賞
2023年7月18日火曜日
当社設立の技術的基盤を形成した論文がFrontier of Science Awardを受賞し、新田尚・代表取締役および合田圭介・取締役らがInternational Congress of Basic Science (ICBS)第一回大会（中国・北京）にて催された授賞式典に参加しました。
Frontier of Science Awardは過去5年間に発表された論文のうち最も学術的インパクトが高いものを表彰するもので、2018年にCell誌に掲載された“Intelligent Image-Activated Cell Sorting”が理論計算機情報科学分野の受賞論文に選ばれました。受賞論文の責任著者および筆頭著者の合田圭介と新田尚がICBS第一回大会（中国・北京）の開会セレモニーにて行われた受賞式に参加しました。
今回アワードを受賞した論文は内閣府ImPACTプログラム「セレンディピティの計画的創出（合田圭介PM）」の成果として得られた象徴的な研究業績で、科学ジャーナルCellに2018年に掲載されました（詳細はこちら）。文部科学大臣表彰科学技術賞の受賞やBerthold Leibinger Innovationspreis 2020のファイナリスト選出など、これまでも国内外から広く評価されてきました。
株式会社CYBOはこの論文で培った技術を基盤として2018年に設立して以来、ENMAやSHIGIなどの技術開発を進めて参りました。当社は引き続き、画期的な最先端技術を医療など実社会の課題解決に役立てるべく、事業を発展させて参ります。
The paper that formed the technological basis for the establishment of CYBO received the Frontier of Science Award. Nao Nitta, President and CEO, and Keisuke Goda, Director, participated in the award ceremony held at The First International Congress of Basic Science in Beijing, China.
The Frontier of Science Award recognizes the paper with the highest scholarly impact published in the past five years. A research paper entitled "Intelligent Image-Activated Cell Sorting," published in Cell in 2018, has been selected as one of the winners in the field of theoretical computer information science. Keisuke Goda and Nao Nitta, the corresponding author and the first author of the winning paper, participated in the award ceremony held at the opening ceremony of the First ICBS Congress in Beijing, China.
The paper that received the award is an iconic research achievement resulting from the ImPACT program "Planned Serendipity (Keisuke Goda PM)" and was published in the scientific journal Cell in 2018 (details available here). It has been widely recognized internationally, including receiving the Awards for Science and Technology in the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, and being selected as finalists for the Berthold Leibinger Innovationspreis.
Since its establishment in 2018 based on the technology developed in this award-winning paper, CYBO has been developing ENMA and SHIGI, and will continue to develop its business to help solve real-world problems in medicine and other areas with its groundbreaking cutting-edge technology.
